;PMID: 3365254
;source_file_1019.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..53] = [t:0..53]
;1)sentence:[e:59..186] = [t:59..186]
;2)section:[e:190..239] = [t:190..239]
;3)section:[e:243..310] = [t:243..310]
;4)sentence:[e:314..650] = [t:314..650]
;5)sentence:[e:651..854] = [t:651..854]
;6)sentence:[e:855..1012] = [t:855..1012]
;7)sentence:[e:1013..1251] = [t:1013..1251]
;8)section:[e:1255..1299] = [t:1255..1298]
;Sentence Matching Errors
;ERROR_Section end mismatch[e:1255..1299][t:1255..1298]
;Token/POS Errors
;ERROR_Token in entity file but not tree[1298..1299] ]

;section 0 Span:0..53
;Biochem Biophys Res Commun. 1988 Apr 29;152(2):843-8.
(SEC
  (FRAG (NNP:[0..7] Biochem) (NNP:[8..15] Biophys) (NNP:[16..19] Res)
        (NNP:[20..26] Commun) (.:[26..27] .) (CD:[28..32] 1988)
        (NNP:[33..36] Apr) (CD:[37..44] 29;152-LRB-) (CD:[44..45] 2)
        (-RRB-:[45..46] -RRB-) (CD:[46..50] :843) (::[50..51] -)
        (CD:[51..53] 8.)))

;sentence 1 Span:59..186
;A male-specific renal cytochrome P-450 isozyme(s) responsible for mutagenic 
;activation of 3-methoxy-4-aminoazobenzene in mice.
;[81..108]:cyp450:"cytochrome P-450 isozyme(s)"
;[150..177]:substance:"3-methoxy-4-aminoazobenzene"
(SENT
  (NP-HLN
    (NP (DT:[59..60] A)
      (ADJP (NN:[61..65] male) (HYPH:[65..66] -) (JJ:[66..74] specific))
      (JJ:[75..80] renal)
      
      (NML (NN:[81..91] cytochrome) (NN:[92..97] P-450))
      (NN:[98..108] isozyme-LRB-s-RRB-))
    (ADJP (JJ:[109..120] responsible)
      (PP (IN:[121..124] for)
        (NP
          (NP (JJ:[125..134] mutagenic) (NN:[136..146] activation))
          (PP (IN:[147..149] of)
            (NP (NN:[150..177] 3-methoxy-4-aminoazobenzene)))
          (PP-LOC (IN:[178..180] in)
            (NP (NNS:[181..185] mice))))))
    (.:[185..186] .)))

;section 2 Span:190..239
;Degawa M, Namiki M, Miura S, Ueno H, Hashimoto Y.
(SEC
  (FRAG (NNP:[190..196] Degawa) (NNP:[197..199] M,) (NNP:[200..206] Namiki)
        (NNP:[207..209] M,) (NNP:[210..215] Miura) (NNP:[216..218] S,)
        (NNP:[219..223] Ueno) (NNP:[224..225] H) (,:[225..226] ,)
        (NNP:[227..236] Hashimoto) (NNP:[237..239] Y.)))

;section 3 Span:243..310
;Department of Hygienic Chemistry, Tohoku University, Sendai, Japan.
(SEC
  (FRAG (NNP:[243..253] Department) (IN:[254..256] of) (NNP:[257..265] Hygienic)
        (NNP:[266..275] Chemistry) (,:[275..276] ,) (NNP:[277..283] Tohoku)
        (NNP:[284..294] University) (,:[294..295] ,) (NNP:[296..302] Sendai)
        (,:[302..303] ,) (NNP:[304..309] Japan) (.:[309..310] .)))

;sentence 4 Span:314..650
;Renal microsomes from male mice (BALB/c, DBA/2 and BALB/c x DBA/2 F1) showed 
;about 10-fold greater activity for mediating mutagenic activation of 
;3-methoxy-4-aminoazobenzene (3-MeO-AAB) toward Salmonella typhimurium TA98
;than  did the corresponding hepatic microsomes, as compared on the basis of
;nmol of  microsomal cytochrome P-450.
;[398..405]:quantitative-value:"10-fold"
;[462..489]:substance:"3-methoxy-4-aminoazobenzene"
;[491..500]:substance:"3-MeO-AAB"
;[613..617]:quantitative-units:"nmol"
;[633..649]:cyp450:"cytochrome P-450"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[314..319] Renal) (NNS:[320..330] microsomes))
      (PP (IN:[331..335] from)
        (NP (JJ:[336..340] male) (NNS:[341..345] mice)))
      (PRN (-LRB-:[346..347] -LRB-)
        (NP
          (NP (NN:[347..353] BALB/c))
          (,:[353..354] ,)
          (NP (NN:[355..360] DBA/2))
          (CC:[361..364] and)
          (NP (NN:[365..371] BALB/c) (SYM:[372..373] x) (NN:[374..379] DBA/2)
              (NN:[380..382] F1)))
        (-RRB-:[382..383] -RRB-)))
    (VP (VBD:[384..390] showed)
      (NP
        (NP
          (ADJP
            (QP (IN:[392..397] about)
               (CD:[398..400] 10) (HYPH:[400..401] -) (RB:[401..405] fold))
            (JJR:[406..413] greater))
          (NN:[414..422] activity))
        (PP (IN:[423..426] for)
          (S-NOM
            (NP-SBJ (-NONE-:[426..426] *))
            (VP (VBG:[427..436] mediating)
              (NP
                (NP (JJ:[437..446] mutagenic) (NN:[447..457] activation))
                (PP (IN:[458..460] of)
                  (NP
                    (NP (NN:[462..489] 3-methoxy-4-aminoazobenzene))
                    (NP (-LRB-:[490..491] -LRB-) (NN:[491..500] 3-MeO-AAB)
                        (-RRB-:[500..501] -RRB-)))))
              (PP (IN:[502..508] toward)
                (NP (NNP:[509..519] Salmonella) (NNP:[520..531] typhimurium)
                    (NN:[532..536] TA98))))))
        (SBAR (IN:[537..541] than)
          (SINV (VBD:[543..546] did)
            (NP-SBJ (DT:[547..550] the) (JJ:[551..564] corresponding)
                    (JJ:[565..572] hepatic) (NNS:[573..583] microsomes))
            (VP (-NONE-:[583..583] *?*)))))
      (,:[583..584] ,)
      (SBAR-ADV (IN:[585..587] as)
        (S
          (NP-SBJ-1 (-NONE-:[587..587] *))
          (VP (VBN:[588..596] compared)
            (NP-1 (-NONE-:[596..596] *))
            (PP (IN:[597..599] on)
              (NP
                (NP (DT:[600..603] the) (NN:[604..609] basis))
                (PP (IN:[610..612] of)
                  (NP
                    (NP (NN:[613..617] nmol))
                    (PP (IN:[618..620] of)
                      (NP (JJ:[622..632] microsomal)
                         (NN:[633..643] cytochrome) (NN:[644..649] P-450)))))))))))
    (.:[649..650] .)))

;sentence 5 Span:651..854
;On the other hand, female renal microsomes and  other extrahepatic microsomes
;(lung, small intestine and colon) in both sexes of  mice showed little or no
;activity for converting 3-MeO-AAB to mutagen(s).
;[830..839]:substance:"3-MeO-AAB"
;[843..853]:substance:"mutagen(s)"
(SENT
  (S
    (PP (IN:[651..653] On)
      (NP (DT:[654..657] the) (JJ:[658..663] other) (NN:[664..668] hand)))
    (,:[668..669] ,)
    (NP-SBJ
      (NP
        (NP (JJ:[670..676] female) (JJ:[677..682] renal)
            (NNS:[683..693] microsomes))
        (CC:[694..697] and)
        (NP (JJ:[699..704] other) (JJ:[705..717] extrahepatic)
            (NNS:[718..728] microsomes)
          (PRN (-LRB-:[729..730] -LRB-)
            (NP
              (NP (NN:[730..734] lung))
              (,:[734..735] ,)
              (NP (JJ:[736..741] small) (NN:[742..751] intestine))
              (CC:[752..755] and)
              (NP (NN:[756..761] colon)))
            (-RRB-:[761..762] -RRB-))))
      (PP-LOC (IN:[763..765] in)
        (NP
          (NP (DT:[766..770] both) (NNS:[771..776] sexes))
          (PP (IN:[777..779] of)
            (NP (NNS:[781..785] mice))))))
    (VP (VBD:[786..792] showed)
      (NP
        (NP
          (NP (JJ:[793..799] little)
            (NML-1 (-NONE-:[799..799] *P*)))
          (CC:[800..802] or)
          (NP (DT:[803..805] no)
            (NML-1 (NN:[806..814] activity))))
        (PP (IN:[815..818] for)
          (S-NOM
            (NP-SBJ (-NONE-:[818..818] *))
            (VP (VBG:[819..829] converting)
              (NP (NN:[830..839] 3-MeO-AAB))
              (PP (TO:[840..842] to)
                (NP (NNS:[843..853] mutagen-LRB-s-RRB-))))))))
    (.:[853..854] .)))

;sentence 6 Span:855..1012
;The  mutagenic activation of 3-MeO-AAB with the male renal enzyme(s) was
;definitely  inhibited by cytochrome P-450 inhibitors, 7,8-benzoflavone and
;SKF 525A.
;[884..893]:substance:"3-MeO-AAB"
;[914..923]:cyp450:"enzyme(s)"
;[953..969]:cyp450:"cytochrome P-450"
;[970..980]:substance:"inhibitors"
;[982..998]:substance:"7,8-benzoflavone"
;[1003..1011]:substance:"SKF 525A"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[855..858] The) (JJ:[860..869] mutagenic)
          (NN:[870..880] activation))
      (PP (IN:[881..883] of)
        (NP (NN:[884..893] 3-MeO-AAB)))
      (PP (IN:[894..898] with)
        (NP (DT:[899..902] the) (JJ:[903..907] male) (JJ:[908..913] renal)
            (NN:[914..923] enzyme-LRB-s-RRB-))))
    (VP (VBD:[924..927] was)
      (ADVP (RB:[928..938] definitely))
      (VP (VBN:[940..949] inhibited)
        (NP-1 (-NONE-:[949..949] *))
        (PP (IN:[950..952] by)
          (NP-LGS
            (NP
              (NML (NN:[953..963] cytochrome) (NN:[964..969] P-450))
              (NNS:[970..980] inhibitors))
            (IN:[980..981] ,)
            (NP
              (NP (NN:[982..998] 7,8-benzoflavone))
              (CC:[999..1002] and)
              (NP (NN:[1003..1006] SKF) (NN:[1007..1011] 525A)))))))
    (.:[1011..1012] .)))

;sentence 7 Span:1013..1251
;All  these findings suggest that in mice, there is a male-specific renal
;3-MeO-AAB  activation enzyme(s), a cytochrome P-450 isozyme(s), which is
;different, at  least in proportion and/or in nature, from hepatic cytochrome
;P-450 isozymes.
;[1086..1095]:substance:"3-MeO-AAB"
;[1108..1117]:cyp450:"enzyme(s)"
;[1121..1148]:cyp450:"cytochrome P-450 isozyme(s)"
;[1225..1250]:cyp450:"cytochrome P-450 isozymes"
(SENT
  (S
    (NP-SBJ (PDT:[1013..1016] All) (DT:[1018..1023] these)
            (NNS:[1024..1032] findings))
    (VP (VBP:[1033..1040] suggest)
      (SBAR (IN:[1041..1045] that)
        (S
          (PP-LOC (IN:[1046..1048] in)
            (NP (NNS:[1049..1053] mice)))
          (,:[1053..1054] ,)
          (NP-SBJ (EX:[1055..1060] there))
          (VP (VBZ:[1061..1063] is)
            (NP-PRD
              (NP
                (NP (DT:[1064..1065] a)
                  (ADJP (NN:[1066..1070] male) (HYPH:[1070..1071] -)
                        (JJ:[1071..1079] specific))
                  (JJ:[1080..1085] renal)
                  (NML (NN:[1086..1095] 3-MeO-AAB) (NN:[1097..1107] activation))
                  (NN:[1108..1117] enzyme-LRB-s-RRB-))
                (,:[1117..1118] ,)
                (NP (DT:[1119..1120] a)
                  
                  (NML (NN:[1121..1131] cytochrome) (NN:[1132..1137] P-450))
                  (NN:[1138..1148] isozyme-LRB-s-RRB-))
                (,:[1148..1149] ,))
              (SBAR
                (WHNP-1 (WDT:[1150..1155] which))
                (S
                  (NP-SBJ-1 (-NONE-:[1155..1155] *T*))
                  (VP (VBZ:[1156..1158] is)
                    (ADJP-PRD (JJ:[1159..1168] different) (,:[1168..1169] ,)
                      (PP
                        (PP
                          (ADVP (IN:[1170..1172] at) (JJS:[1174..1179] least))
                          (IN:[1180..1182] in)
                          (NP (NN:[1183..1193] proportion)))
                        (CC:[1194..1200] and/or)
                        (PP (IN:[1201..1203] in)
                          (NP (NN:[1204..1210] nature))))
                      (,:[1210..1211] ,)
                      (PP (IN:[1212..1216] from)
                        (NP (JJ:[1217..1224] hepatic)
                          
                          (NML (NN:[1225..1235] cytochrome)
                               (NN:[1236..1241] P-450))
                          (NNS:[1242..1250] isozymes))))))))))))
    (.:[1250..1251] .)))

;section 8 Span:1255..1298
;PMID: 3365254 [PubMed - indexed for MEDLINE
(SEC
  (FRAG (NNP:[1255..1259] PMID) (::[1259..1260] :) (CD:[1261..1268] 3365254)
        (-LRB-:[1269..1270] -LSB-) (NNP:[1270..1276] PubMed) (::[1277..1278] -)
        (VBN:[1279..1286] indexed) (IN:[1287..1290] for)
        (NNP:[1291..1298] MEDLINE)))
;ERROR_Orphan Text from EOF Tree File[1298..EOF] ]

(ORPH -RSB-)
